Meghana D Gadgil1, Alka M Kanaya1, Caroline Sands2, Matthew R Lewis2, Namratha R Kandula3, David M Herrington4. 1. Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA. 2. National Phenome Centre, Imperial College London, Hammersmith Hospital Campus, London, UK. 3. Division of General Internal Medicine and Geriatrics, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. 4. Section on Cardiovascular Medicine, Department of Internal Medicine, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, USA.
Abstract
BACKGROUND: South Asians are at higher risk for diabetes (DM) than many other racial/ethnic groups. Circulating metabolites are measurable products of metabolic processes that may explain the aetiology of elevated risk. We characterized metabolites associated with prevalent DM and glycaemic measures in South Asians. METHODS: We included 717 participants from the Mediators of Atherosclerosis in South Asians Living in America (MASALA) study, aged 40-84 years. We used baseline fasting serum for metabolomics and demographic, behavioural, glycaemic data from baseline and at 5 years. We performed LC-MS untargeted metabolomic and lipidomic analysis with targeted integration of known signals. Individual linear and ordinal logistic regression models were adjusted for age, sex, BMI, diet, exercise, alcohol, smoking and family history of DM followed by elastic net regression to identify metabolites most associated with the outcome. RESULTS: There were 258 metabolites with detectable signal in >98% of samples. Thirty-four metabolites were associated with prevalent DM in an elastic net model. Predominant metabolites associated with DM were sphingomyelins, proline (OR 15.86; 95% CI 4.72, 53.31) and betaine (OR 0.03; 0.004, 0.14). Baseline tri- and di-acylglycerols [DG (18:0/16:0) (18.36; 11.79, 24.92)] were positively associated with fasting glucose and long-chain acylcarnitines [CAR 26:1 (-0.40; -0.54, -0.27)] were inversely associated with prevalent DM and HbA1c at follow-up. DISCUSSION: A metabolomic signature in South Asians may help determine the unique aetiology of diabetes in this high-risk ethnic group. Future work will externally validate our findings and determine the effects of modifiable risk factors for DM.
BACKGROUND: South Asians are at higher risk for diabetes (DM) than many other racial/ethnic groups. Circulating metabolites are measurable products of metabolic processes that may explain the aetiology of elevated risk. We characterized metabolites associated with prevalent DM and glycaemic measures in South Asians. METHODS: We included 717 participants from the Mediators of Atherosclerosis in South Asians Living in America (MASALA) study, aged 40-84 years. We used baseline fasting serum for metabolomics and demographic, behavioural, glycaemic data from baseline and at 5 years. We performed LC-MS untargeted metabolomic and lipidomic analysis with targeted integration of known signals. Individual linear and ordinal logistic regression models were adjusted for age, sex, BMI, diet, exercise, alcohol, smoking and family history of DM followed by elastic net regression to identify metabolites most associated with the outcome. RESULTS: There were 258 metabolites with detectable signal in >98% of samples. Thirty-four metabolites were associated with prevalent DM in an elastic net model. Predominant metabolites associated with DM were sphingomyelins, proline (OR 15.86; 95% CI 4.72, 53.31) and betaine (OR 0.03; 0.004, 0.14). Baseline tri- and di-acylglycerols [DG (18:0/16:0) (18.36; 11.79, 24.92)] were positively associated with fasting glucose and long-chain acylcarnitines [CAR 26:1 (-0.40; -0.54, -0.27)] were inversely associated with prevalent DM and HbA1c at follow-up. DISCUSSION: A metabolomic signature in South Asians may help determine the unique aetiology of diabetes in this high-risk ethnic group. Future work will externally validate our findings and determine the effects of modifiable risk factors for DM.
Authors: Timothy R Koves; John R Ussher; Robert C Noland; Dorothy Slentz; Merrie Mosedale; Olga Ilkayeva; James Bain; Robert Stevens; Jason R B Dyck; Christopher B Newgard; Gary D Lopaschuk; Deborah M Muoio Journal: Cell Metab Date: 2008-01 Impact factor: 27.287
Authors: Linda E Kelemen; Sonia S Anand; Vladimir Vuksan; Qilong Yi; Koon K Teo; Sudarshan Devanesen; Salim Yusuf Journal: J Am Diet Assoc Date: 2003-09
Authors: Matthew R Lewis; Jake T M Pearce; Konstantina Spagou; Martin Green; Anthony C Dona; Ada H Y Yuen; Mark David; David J Berry; Katie Chappell; Verena Horneffer-van der Sluis; Rachel Shaw; Simon Lovestone; Paul Elliott; John Shockcor; John C Lindon; Olivier Cloarec; Zoltan Takats; Elaine Holmes; Jeremy K Nicholson Journal: Anal Chem Date: 2016-08-26 Impact factor: 6.986
Authors: Caroline J Sands; Arnaud M Wolfer; Gonçalo D S Correia; Noureddin Sadawi; Arfan Ahmed; Beatriz Jiménez; Matthew R Lewis; Robert C Glen; Jeremy K Nicholson; Jake T M Pearce Journal: Bioinformatics Date: 2019-12-15 Impact factor: 6.937
Authors: Alka M Kanaya; David Herrington; Eric Vittinghoff; Susan K Ewing; Kiang Liu; Michael J Blaha; Swapna S Dave; Fareeha Qureshi; Namratha R Kandula Journal: Diabetes Care Date: 2014-04-04 Impact factor: 19.112
Authors: Meghana D Gadgil; Monika Sarkar; Caroline Sands; Matthew R Lewis; David M Herrington; Alka M Kanaya Journal: Diabetes Res Clin Pract Date: 2022-03-12 Impact factor: 8.180